rimonabant [orch, phsu]
hydrochloride [inch, phsu]
investigational agent [phsu]
Management [ocac]
cardiovascular risk factor [dsyn]
rimonabant [orch, phsu]
hydrochloride [inch, phsu]
Drug [phsu]
Class [inpr]
Cannabinoid Receptor Antagonists [phsu]
Type 1 [clas]
promise [idcn]
Clinical Trials [resa]
treatment [ftcn]
Obesity [dsyn]
Metabolic [ftcn]
risk factors [qnco]
Tobacco Dependence [mobd]
Clinical Trials, Phase III [resa]
rimonabant [orch, phsu]
placebo [topp]
Overweight [sosy]
Obese [dsyn]
Patients [podg]
untreated [fndg]
Dyslipidaemia [dsyn]
Type 2 Diabetes [dsyn]
Lost [ftcn]
Body Weight [orga]
treated [topp]
rimonabant [orch, phsu]
mg% [qnco]
Weight Loss [fndg]
Decrease [qlco]
Waist Circumference [clna]
reduction [npop]
Obesity, Abdominal [dsyn]
Independent [idcn]
Marker [clna]
Cardiovascular disease [dsyn]
Improvement [cnce]
Observed [ftcn]
Lipid [lipd]
Profile [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Decrease [qlco]
Triglyceride level [lbtr]
Improvement [cnce]
Glucose tolerance [phsf]
insulin levels [lbpr]
Patients [podg]
Diagnosed [fndg]
Metabolic syndrome [dsyn]
baseline [bodm]
Reduced [qlco]
effects [qlco]
rimonabant [orch, phsu]
mg% [qnco]
Maintained [ftcn]
chronic [tmco]
treatment [ftcn]
Phase III Trials [resa]
rimonabant [orch, phsu]
Help [socb]
People [popg]
quit [idcn]
Smoking [inbe]
Post [tmco]
Cessation [acty]
Weight Gain [fndg]
rimonabant [orch, phsu]
Favorable [qlco]
Safety [hcpp]
Profile [lbpr]
Well [qlco]
rimonabant [orch, phsu]
Very [qlco]
promise [idcn]
Approach [spco]
Managing [ocac]
Preventable [inpr]
risk factors [qnco]
Cardiovascular disease [dsyn]
Available [ftcn]
Efficacy [qlco]
Safety [hcpp]
rimonabant [orch, phsu]
therapy [ftcn]
Obesity [dsyn]
Smoking Cessation [inbe]
Science [ocdi]
Reserve [acty]
